Literature DB >> 11711528

Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.

F Zannad1, B Dousset, F Alla.   

Abstract

Cardiac extracellular matrix undergoes extensive and continuous turnover involved in the lesion-reparation process, such as in cardiac remodeling, in hypertensive cardiac hypertrophy, in dilated cardiomyopathy, after myocardial infarction in the transition to heart failure, and during the progression of left ventricular dysfunction. Cardiac fibrosis is a major determinant of diastolic dysfunction and pumping capacity, and it may provide the structural substrate for arrhythmogenicity, thus potentially contributing the to progression of heart failure and sudden death. Aldosterone was shown to promote cardiac fibrosis in various experimental models. It was demonstrated that spironolactone may oppose the effect of aldosterone in promoting cardiac fibrosis. Measurement of cardiac collagen turnover by use of serological markers is a useful tool for monitoring cardiac tissue repair and fibrosis in experimental models or clinical conditions. We found that high serum levels of a marker of collagen turnover (procollagen type III N-terminal peptide ) in patients with chronic heart failure receiving conventional therapy, including ACE inhibitors, was associated with high mortality and hospitalization rates. In RALES (Randomized Aldactone Evaluation Study), in patients randomized to placebo, markers continued to increase or remained unchanged after 6-month follow-up. On the contrary, adding spironolactone 25 mg daily significantly decreased the levels of these serum markers during the same period. Most importantly, the spironolactone-related morbidity and mortality benefit was most predominant in subgroups with highest baseline levels of serum markers. These results suggest that limitation of the aldosterone-related excessive extracellular matrix turnover may be one of the various extrarenal mechanisms contributing to the beneficial effect of spironolactone in patients with chronic heart failure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11711528     DOI: 10.1161/hy1101.099484

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  22 in total

Review 1.  Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.

Authors:  W H Wilson Tang; Gary S Francis
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

2.  B-type natriuretic peptide and extracellular matrix protein interactions in human cardiac fibroblasts.

Authors:  Brenda K Huntley; Tomoko Ichiki; S Jeson Sangaralingham; Horng H Chen; John C Burnett
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

3.  Effect of aldosterone antagonism on exercise tolerance, Doppler diastolic function, and quality of life in older women with diastolic heart failure.

Authors:  Kurt R Daniel; Gretchen Wells; Kathryn Stewart; Brian Moore; Dalane W Kitzman
Journal:  Congest Heart Fail       Date:  2009 Mar-Apr

Review 4.  Diastolic heart failure in the elderly and the potential role of aldosterone antagonists.

Authors:  Ashwani Kumar; Gary Meyerrose; Vineeta Sood; Chanwit Roongsritong
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

5.  Advances in diastolic heart failure.

Authors:  Xing Sheng Yang; Jing Ping Sun
Journal:  World J Cardiol       Date:  2010-03-26

6.  A propensity-matched study of low serum potassium and mortality in older adults with chronic heart failure.

Authors:  A Brent Alper; Ruth C Campbell; Stefan D Anker; George Bakris; Christy Wahle; Thomas E Love; L Lee Hamm; Marjan Mujib; Ali Ahmed
Journal:  Int J Cardiol       Date:  2008-08-08       Impact factor: 4.164

Review 7.  Extracellular matrix fibrotic markers in heart failure.

Authors:  Faiez Zannad; Patrick Rossignol; Wafae Iraqi
Journal:  Heart Fail Rev       Date:  2010-07       Impact factor: 4.214

8.  Aldosterone induces elastin production in cardiac fibroblasts through activation of insulin-like growth factor-I receptors in a mineralocorticoid receptor-independent manner.

Authors:  Severa Bunda; Peter Liu; Yanting Wang; Kela Liu; Aleksander Hinek
Journal:  Am J Pathol       Date:  2007-09       Impact factor: 4.307

9.  Aldosterone stimulates elastogenesis in cardiac fibroblasts via mineralocorticoid receptor-independent action involving the consecutive activation of Galpha13, c-Src, the insulin-like growth factor-I receptor, and phosphatidylinositol 3-kinase/Akt.

Authors:  Severa Bunda; Yanting Wang; Thomas F Mitts; Peter Liu; Sara Arab; Majid Arabkhari; Aleksander Hinek
Journal:  J Biol Chem       Date:  2009-04-16       Impact factor: 5.157

10.  A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure.

Authors:  Ali Ahmed; Faiez Zannad; Thomas E Love; Jose Tallaj; Mihai Gheorghiade; Olaniyi James Ekundayo; Bertram Pitt
Journal:  Eur Heart J       Date:  2007-06       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.